Eli Lilly

Eli Lilly Partners with Blacksmith Medicines in $300 Million Seed Funding Deal
BioSpace
Sat, 01/9/21 - 07:52 pm
Eli Lilly
Blacksmith Medicines
funding
metalloenzyme targets
BioGeneration Ventures closes 4th fund, with $170M in tow for early European biotechs
Fierce Biotech
Thu, 01/7/21 - 11:04 pm
BioGeneration Ventures
venture capital
Europe
Bristol Myers Squibb
Eli Lilly
Novo Holdings
Dermira vets license back candidates from Eli Lilly to launch their own upstart
Endpoints
Thu, 01/7/21 - 11:35 am
Demira
Eli Lilly
Evommune
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
Eli Lilly's transpacific bosom buddy Terns bags late-round funding to drive NASH hopefuls through the clinic
Endpoints
Tue, 01/5/21 - 10:03 am
NASH
Terns Pharmaceuticals
Eli Lilly
Eli Lilly to buy New York drugmaker for up to $1B
Beckers Hospital Review
Thu, 12/31/20 - 11:59 am
Eli Lilly
Prevail Therapeutics
M&A
neurodegenerative disease
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
Thu, 12/17/20 - 06:25 pm
GSK
Vir Biotechnology
Eli Lilly
antibodies
NIH
COVID-19
clinical trials
Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?
Fierce Pharma
Thu, 12/17/20 - 06:19 pm
FDA
Eli Lilly
Regeneron
antibodies
COVID-19
13 drugmakers contracted by Operation Warp Speed in 2020
Beckers Hospital Review
Wed, 12/16/20 - 10:36 pm
HHS
Operation Warp Speed
COVID-19
vaccines
Cytiva
Eli Lilly
AstraZeneca
Emergent BioSolutions
Fujifilm
JNJ
Moderna Therapeutics
Pfizer
BioNTech
Novavax
Regeneron
Sanofi
GSK
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Drugs.com
Tue, 12/15/20 - 08:24 pm
Eli Lilly
tirzepatide
clinical trials
type 2 diabetes
diabetes
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
Biopharma Reporter
Tue, 12/15/20 - 10:57 am
Eli Lilly
Prevail Therapeutics
M&A
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Fierce Biotech
Wed, 12/9/20 - 10:46 am
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Physicians express skepticism about Lilly arthritis drug OK'd as COVID-19 treatment
Beckers Hospital Review
Tue, 12/8/20 - 10:33 am
Eli Lilly
olumiant
COVID-19
physicians
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
Fierce Biotech
Mon, 12/7/20 - 10:37 am
AbCellera
Eli Lilly
R&D
Canada
COVID-19
antibodies
IPOs
#ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
Endpoints
Sat, 12/5/20 - 11:28 pm
ASH2020
Eli Lilly
clinical trials
LOXO-305
Loxo Oncology
mantle cell lymphoma
non-Hodgkin lymphoma
[video+transcript]Here's Why Biotech Deals Are All the Rage Right Now
Motley Fool
Sat, 12/5/20 - 11:24 pm
biotech
M&A
Biogen
SAGE Therapeutics
Eli Lilly
Precision Biosciences
Merck
OncoImmune
Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19
Pharmaceutical Business Review
Thu, 12/3/20 - 10:51 am
Eli Lilly
antibodies
bamlanivimab
COVID-19
government contract
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Wed, 12/2/20 - 10:33 am
Roche
Blueprint Medicines
Gavreto
thyroid cancer
Retevmo
Eli Lilly
Could Eli Lilly and Precision BioSciences Make Breakthroughs for DMD?
BioSpace
Fri, 11/20/20 - 11:09 am
Eli Lilly
Precision Biosciences
Duchenne Muscular Dystrophy
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Endpoints
Thu, 11/19/20 - 11:09 pm
Eli Lilly
FDA
COVID-19
Emergency Use Authorization
olumiant
remdesivir

Pages